Comparison of the Analgesic Effect of 2 Shoulder Infiltrations
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorCentre hospitalier de l'Université de Montréal (CHUM)
About this trial
For patients suffering of osteoarthritis, only analgesic treatments such as anti-inflammatory drugs and cortisone infiltrations provide significant but temporary relief of their pain. The objective is to compare the analgesic effect of 2 infiltrations: Cingal (sodium hyaluronate and triamcinolone) versus cortisone (triamcinolone). It is anticipated that the Cingal infiltration will have a greater analgesic effect than a simple cortisone infiltration in patients with moderate to severe osteoarthritis of the shoulder.
Method:
* Randomized controlled trial * Monocentric * Randomization will be done using sealed envelopes
Eligibility criteria
Qualifiers
A clinical examination that confirms the radiological diagnosis of moderate to severe primary shoulder osteoarthritis, stage II and above, according to the Samilson-Prieto classification.
Patients aged between 20 and 90 years.
A patient with bilateral shoulder osteoarthritis will choose the side of the infiltration, only one side can be chosen to participate in the study.
The patient must have a clinical pain threshold of a minimum of 4/10 on the visual analogue scale.
Disqualifiers
Presence of a transfixing rotator cuff tear assessed on MRI.
No previous shoulder reconstruction surgery.
Pregnant woman.
A patient who has received a cortisone infiltration within 6 months prior to the start of the study.
Trial design
Treatments tested in this trial
- Triamcinolone Hexacetonide and hyaluronic acid
- Triamcinolone Hexacetonide
Treatment groups
84 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov